Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 341 - 360 of 505 trials
Title Investigatorsort icon Disease(s)
A Phase I/II Study of Pomalidomide and Dexamethasone with and without Ixazomib in Patients with Recurrent Multiple Myeloma
[Protocol 14-055]
Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Pilot Study of Bortezomib/Dexamethasone Followed by Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone for the Initial Treatment of MIDD Associated with Multiple Myeloma and Amyloidosis
Newly Diagnosed
[Protocol 11-061]
Hassoun, Hani
  • Hematology
    • Hematologic Disorders
    • Hematologic Malignancies
    • Multiple Myeloma
A Phase II Study of Lenalidomide and Low-Dose Dexamethasone (LD) Followed by Continued LD or Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma
[Protocol 08-121]
Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase II Study of Lenalidomide Intensification in Patients with Asymptomatic Multiple Myeloma that Has Progressed with Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation
Newly Diagnosed
[Protocol 11-107]
Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase I Study of ADI-PEG 20 plus FOLFOX in Patients with Advanced Digestive Cancers
[Protocol 14-153]
Harding, James
  • Colorectal Cancer
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
    • Pancreatic Cancer
A Phase Ib Study of Ramucirumab plus LY2875358 in Patients with Advanced Cancer
[Protocol 14-049]
Harding, James
  • Solid Tumors
A Phase I Study of CB-839 in Patients with Advanced Solid Tumors
[Protocol 14-111]
Harding, James
  • Breast Cancer
  • Colorectal Cancer
  • Head & Neck Cancer
  • Hepatobiliary
    • Pancreatic Cancer
  • Kidney Cancer
  • Lung Cancer, Non-Small Cell
  • Melanoma
  • Mesothelioma
  • Solid Tumors
  • Upper Gastrointestinal
    • Pancreatic Cancer
Ofatumumab with or without Bendamustine for Patients with Mantle Cell Lymphoma Who Cannot Have an Autologous Stem Cell Transplant
Newly Diagnosed
[Protocol 11-050]
Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Brentuximab (SGN-35) Given Before and After Adriamycin, Vinblastine, and Dacarbazine Therapy in Older Adults with Untreated Hodgkin Lymphoma
[Protocol 11-201]
Hamlin, Paul
  • Lymphoma
    • Hodgkin's Disease
A Phase I Study of PRT062070 in Patients with Persistent or Recurrent Chronic Lymphocytic Leukemia, Small Cell Lymphocytic Leukemia, or B-Cell Non-Hodgkin Lymphoma
[Protocol 14-023]
Hamlin, Paul
  • Leukemia
    • Chronic Lymphocytic Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Comprehensive Assessment to Predict Side Effects from Chemotherapy and an Evaluation of Pre-Phase Chemotherapy in Older Patients with Non-Hodgkin Lymphoma
[Protocol 13-028]
Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Bendamustine and Rituximab with or without Ibrutinib in Older Patients with Newly Diagnosed Mantle Cell Lymphoma
[Protocol 13-196]
Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Ibritumomab Tiuxetan versus Observation in Older Patients with Diffuse Large B-Cell Lymphoma in Remission following R-CHOP
Newly Diagnosed
[Protocol 12-061]
Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
Hereditary Colorectal Cancer Family Registry
[Protocol 01-110]
Guillem, Jose
  • Colorectal Cancer
  • Hereditary Cancer & Genetics
A Phase I Study of Pomalidomide in Patients with Recurrent or Persistent Primary Central Nervous System Lymphoma or Primary Vitreoretinal Lymphoma
Relapsed/Refractory
[Protocol 14-003]
Grommes, Christian
  • Brain Tumors, Primary
    • Primary Central Nervous System Lymphoma
  • Lymphoma
A Phase IB Study of MEK162 plus Paclitaxel in Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 12-192]
Grisham, Rachel
  • Ovarian Cancer
A Phase II Study of Pimasertib with SAR245409 or a Placebo in Women with Previously Treated Inoperable Low-Grade Ovarian Cancer
[Protocol 13-173]
Grisham, Rachel
  • Ovarian Cancer
A Phase II Study of Enzalutamide in Patients with Advanced or Recurrent Androgen Receptor-Positive Ovarian Cancer
[Protocol 13-119]
Grisham, Rachel
  • Ovarian Cancer
A Phase III Study of MEK162 versus Standard Chemotherapy in Patients with Recurrent or Persistent Low-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: The MILO Study
[Protocol 13-098]
Grisham, Rachel
  • Ovarian Cancer
A Phase I Study of DS-3032B in Patients with Advanced Solid Tumors or Lymphomas
[Protocol 13-171]
Gounder, Mrinal
  • Lymphoma
  • Solid Tumors